Insulin Autoantibodies Test – Identifying Autoimmune Diabetes
The Insulin Autoantibodies (IAA) Test is used to detect antibodies that the body produces against its own insulin. This is commonly seen in Type 1 diabetes, where the immune system attacks insulin-producing cells in the pancreas.
Indications for Insulin Autoantibodies Test:
● Diagnosis of Type 1 diabetes: When there is suspicion of autoimmune destruction of the pancreas.
● Autoimmune diabetes screening: Particularly useful in individuals under 30 years of age with unexplained high blood sugar levels.
How the Insulin Autoantibodies Test Works:
● A blood sample is tested for autoantibodies against insulin or other pancreatic islet cells. Presence of these antibodies indicates Type 1 diabetes or latent autoimmune diabetes in adults (LADA).
Normal Range:
● Negative result: No insulin autoantibodies present, indicating non-autoimmune diabetes.
Abnormal Test Significance:
● Positive result: Indicates autoimmune diabetes, most often seen in Type 1 diabetes or LADA.
Management Based on Results:
● For Type 1 diabetes: Insulin therapy is required to manage blood glucose levels.
● For LADA: Some individuals may require insulin later, depending on the progression of the autoimmune response.
Price in India:
● Approx. ₹3,000 – ₹6,000.
FAQs
What does a positive insulin autoantibody test mean?
It indicates the presence of autoimmune diabetes, where the body’s immune system attacks its own insulin-producing cells.
Can this test diagnose Type 2 diabetes?
No, the IAA test is primarily used to diagnose Type 1 diabetes or LADA, not Type 2 diabetes.
Disclaimer:
Insulin autoantibody testing is a useful tool for diagnosing autoimmune diabetes, but should be interpreted by a healthcare provider in conjunction with clinical symptoms and other tests.
How HealthPil Can Help:
HealthPil provides endocrinology consultations for autoimmune diabetes and can help interpret insulin autoantibody test results to determine the best treatment plan.